Oaktop Capital Management Ii, L.P.
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 14, 2026), Oaktop Capital Management Ii, L.P. reported 14 stock positions worth $1.3 billion. Its top holding was Lam Research (LRCX) at 35.9% of the portfolio, followed by KLA (KLAC, 34.1%) and Analog Devices (ADI, 11.1%). Compared with Q4 2025, it opened 1 new position, added to 2 and reduced 1. The biggest buy was Aspen Aerogels (ASPN, shares +18%) and the biggest sale Lam Research (LRCX, shares −6%).
- Most Recent 13F
- Q2 2026
- Location
- Chatham, NJ
- CIK
- 0001550660
- Portfolio Value
- $1.3B (Q1 2026)
- SEC Filing
- 0001172661-26-001972 ↗ filed May 14, 2026
Holdings Value
Holdings 14 stocks · $1.3B
| LRCX Lam Research Corp. | 35.86% | 2,249,394 | $480.6M | Reduce -5.9% |
| KLAC KLA Corp. | 34.14% | 310,738 | $457.5M | No change |
| ADI Analog Devices Inc. | 11.07% | 466,196 | $148.3M | No change |
| AVGO Broadcom Inc. | 8.38% | 362,760 | $112.3M | No change |
| BMY Bristol-Myers Squibb Co. | 2.17% | 479,991 | $29.1M | No change |
| DELL Dell Technologies -C | 1.60% | 130,619 | $21.4M | No change |
| EGAN Egain Corp. | 1.57% | 2,671,843 | $21.1M | No change |
| ASPN Aspen Aerogels Inc. | 1.32% | 5,168,674 | $17.7M | Add +17.6% |
| PINS Pinterest Inc. Class A | 1.16% | 850,000 | $15.6M | Add +30.8% |
| PRGS Progress Software Corp. | 0.97% | 508,608 | $13.0M | No change |
| GRMN Garmin Ltd. | 0.83% | 48,000 | $11.1M | No change |
| CEVA Ceva Inc. | 0.62% | 446,377 | $8.3M | No change |
| ARM Arm Holdings PLC-ADR | 0.23% | 20,000 | $3.0M | New |
| INTC Intel Corp. | 0.08% | 23,010 | $1.0M | No change |
Portfolio Sells Q4 2025 → Q1 2026
| LRCX Lam Research Corp. | Reduce -5.9% | 35.86% | +1.18 |
Portfolio Buys Q4 2025 → Q1 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $2.4B | KLAC, LRCX, ADI, AVGO, DELL |
| Q1 2026 | 14 | $1.3B | LRCX, KLAC, ADI, AVGO, BMY |
| Q4 2025 | 13 | $1.2B | LRCX, KLAC, ADI, AVGO, EGAN |
| Q3 2025 | 15 | $1.1B | LRCX, KLAC, AVGO, ADI, ASPN |
| Q2 2025 | 15 | $929.6M | KLAC, LRCX, ADI, AVGO, PRGS |
| Q1 2025 | 15 | $750.8M | KLAC, LRCX, ADI, AVGO, BMY |
| Q4 2024 | 15 | $800.8M | KLAC, LRCX, ADI, AVGO, ASPN |
| Q3 2024 | 15 | $916.3M | KLAC, LRCX, ADI, ASPN, AVGO |
| Q2 2024 | 16 | $976.5M | KLAC, LRCX, ADI, ASPN, AVGO |
| Q1 2024 | 15 | $865.4M | KLAC, LRCX, ADI, ASPN, AVGO |